We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PLSE market cap is 403.64M. The company's latest EPS is USD -0.7676 and P/E is -9.37.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | -9k | 0 | 0 | 0 |
| Operating Income | -18.03M | -8.75M | -9.56M | -10.23M | -11.25M |
| Net Income | -18.04M | -9.2M | -9.8M | -9.91M | -10.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 1.42M | 700k | 0 |
| Operating Income | -47.95M | -49.97M | -63.01M | -58.06M | -43.57M |
| Net Income | -46.97M | -49.85M | -63.66M | -58.51M | -42.21M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 87.57M | 77.88M | 70.22M | 74.76M | 65.95M |
| Total Liabilities | 81.38M | 80.13M | 80.89M | 14.26M | 13.8M |
| Total Equity | 6.19M | -2.25M | -10.67M | 60.5M | 52.15M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.92M | 41.29M | 54.25M | 77.88M | 59.15M |
| Total Liabilities | 11.18M | 18.4M | 18.56M | 80.13M | 14.79M |
| Total Equity | 30.74M | 22.89M | 35.69M | -2.25M | 44.36M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.05M | -47.01M | -6.57M | -15.77M | -26.26M |
| Investing | -360k | -401k | -39k | -55k | -78k |
| Financing | 79.96M | 79.94M | -432k | 13.44M | 15.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.19M | -35.37M | -54.1M | -47.01M | -33.04M |
| Investing | -10.1M | 10.04M | 7.56M | -401k | -121k |
| Financing | 82k | 30.89M | 62.69M | 79.94M | 16.39M |
| Market Cap | 403.64M |
| Price to Earnings Ratio | -9.37 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.91 |
| Price to Book Ratio | 8.91 |
| Dividend Yield | - |
| Shares Outstanding | 54.99M |
| Average Volume (1 week) | 128.27k |
| Average Volume (1 Month) | 188.95k |
| 52 Week Change | 25.04% |
| 52 Week High | 13.62 |
| 52 Week Low | 3.78 |
| Spread (Intraday) | 0.3 (4.08%) |
| Company Name | Pulse Biosciences Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.pulsebiosciences.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
